Risk Factors for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus
Abstract
OBJECTIVE: To identify risk factors for esophageal adenocarcinoma (EAC) in patients with Barrett's esophagus (BE). METHODS: A hospital-based case-control study was performed in which 91 cases with EAC and 244 controls with histologically confirmed BE (>2 cm) with no dysplasia or low-grade dysplasia were included. Information on demographic, anthropometric, and lifestyle characteristics, physical activity levels, working posture, family history, gastroesophageal reflux disease (GERD) symptoms, and medication use was collected by questionnaire. RESULTS: Cases more often were current smokers (odds ratio 3.7, 95% confidence interval 1.4-9.9), more often had a body mass index >25 assessed at age 20 (2.6, 1.2-5.5), and more frequently had been working in a stooped posture at age 20 (2.0, 1.1-3.9), compared to controls. In addition, cases less often experienced symptoms of heartburn (0.3, 0.2-0.5) and less frequently used proton pump inhibitors (0.1, 0.05-0.2), compared to controls, whereas use of nonsteroidal anti-inflammatory drugs/aspirin was more common among cases (1.8, 1.1-3.2). Cases more often were men, compared to controls (91%vs 67%, p < 0.001). CONCLUSION: In patients with BE, the risk of EAC is related to risk factors for GERD, which is, however, asymptomatic. As these risk factors are common in Western countries, they are probably not helpful in individualization of surveillance intervals.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Long-term PPI use significantly decreases the risk of progression to high-grade dysplasia and EAC in patients with non-dysplastic BE.
“because their long-term use significantly decreases the risk of the progression to high-grade dysplasia and EAC[50-52]”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [50]
Cites
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270 · see citing works
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,012 · see citing works
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,382 · see citing works
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,024 · see citing works
Classification of adenocarcinoma of the oesophagogastric junction
Siewert, J. R., & Stein, H. J. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00940.x · Cited by 1,283 · see citing works
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
Pera, M., Cameron, A. J., Trastek, V. F., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90420-h · Cited by 867 · see citing works
Barrett's Esophagus; Development of Dysplasia and Adenocarcinoma
Hameeteman, W. M., Tytgat, G. N. J., Houthoff, H. J., & van den Tweel, J. G. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80011-3 · Cited by 857 · see citing works
The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus
Cameron, A. J., Ott, B. J., & Payne, W. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131404 · Cited by 721 · see citing works
Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia
Lagergren, J., Bergström, R., & Nyrén, O. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00003 · Cited by 675 · see citing works
Spechler, S. J., & Goyal, R. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608073150605 · Cited by 664 · see citing works
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus
Sampliner, R. E. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05910.x · Cited by 650 · see citing works
Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
Chow, W., Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D., Stanford, J. L., Dubrow, R., Schoenberg, J. B., Mayne, S. T., Farrow, D. C., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.150 · Cited by 622 · see citing works
Vaughan, T. L., Davis, S., Kristal, A. R., & Thomas, D. B. (1995) · PubMed · Cited by 516 · see citing works
Reid, B. J., Blount, P. L., Rubin, C. E., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90758-q · Cited by 467 · see citing works
Adenocarcinoma Complicating Columnar Epithelium-lined (Barrett’s) Esophagus
Haggitt, R. C., Tryzelaar, J. F., Ellis, F. H., & Colcher, H. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/70.1.1 · Cited by 452 · see citing works
Adenocarcinoma and Barrett's esophagus. An overrated risk?
Spechler, S. J., Robbins, A. H., Rubins, H. B., et al. (1984) · PubMed · Cited by 437 · see citing works
Continuing Climb in Rates of Esophageal Adenocarcinoma: An Update
Blot, W. J. (1993) · JAMA · doi:10.1001/jama.1993.03510110056031 · Cited by 420 · see citing works
van Sandick, J. W., van Lanschot, J. J. B., Kuiken, B. W., Tytgat, G. N. J., Offerhaus, G. J. A., & Obertop, H. (1998) · Gut · doi:10.1136/gut.43.2.216 · Cited by 391 · see citing works
Adenocarcinoma of the Esophagus: Role of Obesity and Diet
Brown, L. M., Swanson, C. A., Gridley, G., Swanson, G., Schoenberg, J. B., Greenberg, R. S., Silverman, D. T., Pottern, L. M., Hayes, R. B., Schwartz, A. G., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.2.104 · Cited by 372 · see citing works
Adenocarcinoma and Barrett's esophagus
Spechler, S. J., Robbins, A. H., Rubins, H. B., et al. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90090-8 · Cited by 366 · see citing works
Reid, B. J., Prevo, L. J., Galipeau, P. C., Sanchez, C. A., Longton, G., Levine, D. S., Blount, P. L., & Rabinovitch, P. S. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04236.x · Cited by 364 · see citing works
Galipeau, P. C., Cowan, D., Sanchez, C. A., Barrett, M. T., Emond, M. J., Levine, D. S., Rabinovitch, P. S., & Reid, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7081 · Cited by 360 · see citing works
Hamilton, S. R., & Smith, R. R. L. (1987) · American Journal of Clinical Pathology · doi:10.1093/ajcp/87.3.301 · Cited by 353 · see citing works
O'Connor, B. J., Falk, G. W., & Richter, J. E. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01275.x · Cited by 347 · see citing works
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review
Dulai, G. S., Guha, S., Kahn, K. L., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30297 · Cited by 346 · see citing works
Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus
El‐Serag, H. B., Aguirre, T. V., Davis, S., Kuebeler, M. K., Bhattacharyya, A., & Sampliner, R. E. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30228.x · Cited by 329 · see citing works
Increasing incidence of Barrett's oesophagus in the general population
van Soest, E. M. (2005) · Gut · doi:10.1136/gut.2004.063685 · Cited by 322 · see citing works
Wu, A. H., Wan, P. C., & Bernstein, L. (2001) · Cancer Causes & Control · doi:10.1023/a:1011290704728 · Cited by 297 · see citing works
Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia
Kabat, G. C., Ng, S. K. C., & Wynder, E. L. (1993) · Cancer Causes & Control · doi:10.1007/bf00053153 · Cited by 285 · see citing works
Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux
Solaymani–Dodaran, M., Logan, R. F. A., West, J., et al. (2004) · Gut · doi:10.1136/gut.2003.028076 · Cited by 281 · see citing works
Weston, A. P., Badr, A. S., & HASSANEIN, R. S. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01602.x · Cited by 201 · see citing works
Barrett’s oesophagus: from metaplasia to dysplasia and cancer
Fléjou, J. (2005) · Gut · doi:10.1136/gut.2004.041525 · Cited by 184 · see citing works
Forsyth, P. A., Shaw, E. G., Scheithauer, B. W., O'Fallon, J. R., Layton, D. D., & Katzmann, J. A. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4 · Cited by 173 · see citing works
Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma
Wong, A., & Fitzgerald, R. C. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00602-0 · Cited by 148 · see citing works
Primary Adenocarcinoma of the Esophagus
Raphael, H. A., Ellis, F. H., & Dockektv, M. B. (1966) · Annals of Surgery · doi:10.1097/00000658-196611000-00002 · Cited by 127 · see citing works
Primary adenocarcinoma of the esophagus
Turnbull, A. D., & Goodner, J. T. (1968) · Cancer · doi:10.1002/1097-0142(196811)22:5 · Cited by 114 · see citing works
Gopal, D. V., Lieberman, D. A., Magaret, N. D., et al. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024715824149 · Cited by 113 · see citing works
Hage, M., Siersema, P. D., Dekken, H. V., et al. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410003524 · Cited by 110 · see citing works
Self-citationGray, M. R., Donnelly, R. J., & Kingsnorth, A. N. (1993) · Gut · doi:10.1136/gut.34.6.727 · Cited by 102 · see citing works
Continuing climb in rates of esophageal adenocarcinoma: an update
Blot, W. J. (1993) · JAMA · doi:10.1001/jama.270.11.1320 · Cited by 81 · see citing works
Azzopardi, J. G., & Menzies, T. (1962) · British journal of surgery · doi:10.1002/bjs.18004921703 · Cited by 79 · see citing works
The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagus
Levi, F., Olloy, J., Vecchia, C. L., et al. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450511 · Cited by 71 · see citing works
Bártková, J., Thullberg, M., Meyts, E. R., Skakkebæk, N. E., & Bartek, J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3 · Cited by 70 · see citing works
A morphometric study of neovascularization in colorectal carcinoma
Pavlopoulos, P. M., Konstantinidou, A. E., Agapitos, E. B., Kavantzas, N., Nikolopoulou, P., & Davaris, P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 54 · see citing works
Jankowski, J. A., & Anderson, M. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02143.x · Cited by 44 · see citing works
Adenocarcinoma of the Esophagus With and Without Barrett Mucosa
Sabel, M. S. (2000) · Archives of Surgery · doi:10.1001/archsurg.135.7.831 · Cited by 41 · see citing works
Slehria, S., & Sharma, P. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200307000-00011 · Cited by 10 · see citing works
Adenocarcinoma in situ arising from the submucosal oesophageal mucous glands
Fabre, A., Tansey, D., Dave, U., et al. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200309000-00018 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G., & El-Serag, H. B. (2014) · Gut · doi:10.1136/gutjnl-2013-305997 · Cited by 298 · see citing works
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258 · see citing works
- Authors
- de Jonge, P. J. F., Steyerberg, E. W., Kuipers, E. J., Honkoop, P., Wolters, L. M. M., Kerkhof, M., van Dekken, H., & Siersema, P. D.
- Affiliations
- Erasmus MC (NL)
- Corresponding author
- Siersema, Peter D
- Venue
- The American Journal of Gastroenterology
- Published
- 2006-07
- Volume
- 101
- Issue
- 7
- Pages
- 1421-1429
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W2066962389
- Cited by
- 104
- References
- 48
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 8 · 2020: 3 · 2019: 7 · 2018: 2 · 2017: 9 · 2016: 3 · 2015: 9 · 2014: 7 · 2013: 8 · 2012: 3
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Surgery › Esophageal and GI Pathology
- Keywords
- esophageal adenocarcinoma, Barrett's esophagus, risk factors, gastroesophageal reflux disease, smoking, body mass index, proton pump inhibitors, nonsteroidal anti-inflammatory drugs, aspirin, surveillance interval
- MeSH terms
- Adenocarcinoma, Anti-Inflammatory Agents, Non-Steroidal, Anti-Ulcer Agents, Barrett Esophagus, Educational Status, Esophageal Neoplasms, Female, Humans, Male, Middle Aged, Netherlands, Posture, Surveys and Questionnaires, Risk Factors, Smoking, Body Mass Index, Chi-Square Distribution, Logistic Models, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review